XLON
ELM
Market cap1.36bUSD
Oct 09, Last price
182.20GBP
1D
1.90%
1Q
16.05%
Jan 2017
-28.23%
Name
Elementis PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Elementis plc functions as a global producer of specialty chemicals, maintaining operations across the United Kingdom, North America, other European regions, and various international markets. Its business activities are structured into four key divisions: Personal Care, Coatings, Talc, and Chromium. The Personal Care segment manufactures and supplies rheology modifiers and specialized compounded products for use in antiperspirants, deodorants, bath and soap formulations, color cosmetics, and both hair and skin care items. Within the Coatings division, Elementis develops and markets rheological modifiers and a range of additives tailored for industrial finishes, architectural paints, construction materials, adhesives, sealants, printing inks, colorant dispersions, and numerous specialized uses. This segment also provides bentonite and hectorite clays, along with polymer-based additives crucial for drilling, simulation, and cementing operations. The Talc segment is responsible for extracting and distributing talc, which is integral to the production of plastics, paints and coatings, food and pharmaceutical items, ceramics, polyester putties, and within the paper and pulp industries. Elementis' Chromium division manufactures a diverse array of chromium chemicals, including chromic oxide, chromic acid, chrome sulfate, sodium dichromate, and sodium sulfate. These compounds find extensive utility in areas such as pigments, cosmetics, refractories, chrome metal manufacturing, finishing processes for metals and plastics, wood treatment, leather tanning, trivalent metal finishing, various coatings, and metal passivation. Moreover, they are employed in the formulation of detergents, glasses, papers, and starches. Beyond these core operations, Elementis plc also supplies a broader range of products, such as personal care formulations, waxes, various additives and resins, organoclays, colorants, and other specialized chemical enhancements. Established in 1844, Elementis plc maintains its corporate headquarters in London, UK.
Related entities
Subsidiaries (3)
ELEMENTIS GLOBAL LLC
ELEMENTIS HOLDINGS LIMITED
ELEMENTIS SPECIALTIES (INDIA) PRIVATE LIMITED
Key people
Kath Kearney-Croft
Chief Financial Officer · since 2026
Stijn Dejonckheere
Senior Vice President - Global Personal Care · since 2020
Joe Lupia
Senior Vice President - Global Technology · since 2019
Luc Van Ravenstein
Chief Executive Officer, Executive Director · since 2025
Anna Lawrence
Group General Counsel, Company Secretary · since 2022
Non-Executive Director · since 2025
Independent Non-Executive Chairman of the Board · since 2021
Independent Non-Executive Director · since 2024
Maria Ciliberti
Independent Non-Executive Director · since 2024
Independent Non-Executive Director · since 2017
Geertrui Schoolenberg
Senior Independent Director · since 2022
Independent Non-Executive Director · since 2020
Independent Non-Executive Director · since 2022
Headquarters & legal address
THE BINDERY, 5TH FLOOR
51-53 HATTON GARDEN
LONDON, LND EC1N 8HN
GB
51-53 HATTON GARDEN
LONDON, LND EC1N 8HN
GB
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||